Clinical profile of acute myocardial infarction in elderly (prospective study)

M P Holay1, A Janbandhu, A Javahirani

  • 1Department of Medicine, Indira Gandhi Govt. Medical College, Nagpur.

Insights

Elderly patients experiencing acute myocardial infarction (AMI) present with atypical symptoms and receive less treatment. They face significantly higher complication and mortality rates compared to younger individuals.

Area of Science:

  • Cardiology
  • Geriatric Medicine

Background:

  • Heart disease is a leading cause of death and hospitalization in the elderly.
  • Conventional cardiovascular risk factors in older adults are not well understood.
  • Acute myocardial infarction (AMI) often presents atypically in elderly patients.

Purpose of the Study:

  • To describe risk factors, clinical features, and outcomes of AMI in patients over 60 years old.
  • To compare these factors in elderly patients versus younger patients (<60 years).
  • To investigate complications within 30 days of AMI.

Main Methods:

  • Prospective observational cross-sectional analytical study.
  • 120 AMI cases divided into two groups: Group I (<60 years) and Group II (>60 years).
  • Analysis of clinical history, risk factors, complications, and 30-day follow-up.

Main Results:

  • Elderly patients (Group II) showed predominantly atypical chest pain, sweating, dyspnoea, and giddiness.
  • Delayed hospital arrival (within 6 hours) was more common in the elderly (46.8%) vs. younger patients (71.4%).
  • Elderly patients had higher rates of major complications (congestive cardiac failure, arrhythmias, AV block) and mortality (39% vs. 12.5%).
  • Underutilization of thrombolytic therapy and beta-blockers was noted in the elderly group.

Conclusions:

  • Acute myocardial infarction (AMI) manifestations are subtler in the elderly, with distinct risk factors.
  • Elderly patients with AMI are undertreated, leading to higher complication and mortality rates.
  • Age is a significant factor influencing AMI presentation, management, and outcomes.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...